Commentary
Should the ApoE genotype be a covariate for clinical trials in Alzheimer disease?
-
Correspondence: Martin R Farlow mfarlow@iupui.edu
Alzheimers Res Ther 2010, 2:15 doi:10.1186/alzrt39
No comments have yet been made on this article.